Login / Signup

A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation.

Yang YiYanqiang LiQingshu MengQiaqia LiFuxi LiBing LuJiangchuan ShenLadan FazliDongyu ZhaoChao LiWeihua JiangRui WangQipeng LiuAileen SzczepanskiQianru LiWei QinAdam B WeinerTamara L LotanZhe JiSundeep KalantryLu WangEdward M SchaefferHengyao NiuXuesen DongWei ZhaoKaifu ChenQi Cao
Published in: Nature cell biology (2021)
Dysregulated translation is a common feature of cancer. Uncovering its governing factors and underlying mechanism are important for cancer therapy. Here, we report that enhancer of zeste homologue 2 (EZH2), previously known as a transcription repressor and lysine methyltransferase, can directly interact with fibrillarin (FBL) to exert its role in translational regulation. We demonstrate that EZH2 enhances rRNA 2'-O methylation via its direct interaction with FBL. Mechanistically, EZH2 strengthens the FBL-NOP56 interaction and facilitates the assembly of box C/D small nucleolar ribonucleoprotein. Strikingly, EZH2 deficiency impairs the translation process globally and reduces internal ribosome entry site (IRES)-dependent translation initiation in cancer cells. Our findings reveal a previously unrecognized role of EZH2 in cancer-related translational regulation.
Keyphrases
  • long noncoding rna
  • long non coding rna
  • cancer therapy
  • transcription factor
  • genome wide
  • dna methylation
  • machine learning
  • drug delivery
  • squamous cell carcinoma
  • papillary thyroid
  • single cell